Shang-Hung Chang

TL;DR: Use of non–vitamin K oral anticoagulants with or without concurrent use of atorvastatin, digoxin, and erythromycin or clarithromycin compared with the use of NOACs alone was associated with increased risk of major bleeding, and concurrent use of amiodarone, fluconazole, rifampin, and phenytoin with NOacs had a significant increase in adjusted incidence rates.

TL;DR: Metformin use was associated with a decreased risk of AF in patients with type 2 DM who were not using other anti-diabetic medication, probably via attenuation of atrial cell tachycardia-induced myolysis and oxidative stress.

TL;DR: In real-world practice among Asians with NVAF, both rivaroxaban and dabigatran were associated with reduced risk for ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality without significantly increased risk for acute myocardial infarction or hospitalization for gastrointestinal bleeding compared with warfarin.

TL;DR: The endovascular intervention provides compatible, even better early postoperative outcomes for visceral artery aneurysms to surgery, and concomitant malignancy was the major determinant of visceral arteryAneurysm, both in-hospital death and survival.

TL;DR: All NOACs were associated with lower risk of IS/SE, major bleeding, and mortality compared with warfarin in the largest real‐world practice among Asians with nonvalvular atrial fibrillation.